Neural transplantation as an experimental treatment modality for cerebral ischemia

Neuroscience and Biobehavioral Reviews

Volumn 21, Issue 1, 1997, Pages 79-90

  Borlongan, Cesario V ^a   Koutouzis, Theodore K ^a   Jorden, Jeffrey R ^a   Martinez, Rodrigo ^a   Rodriguez, Alba I ^a   Poulos, Stephen G ^a   Freeman, Thomas B ^a   McKeown, Peter ^a   Cahill, David W ^a   Nishino, Hitoo ^b   Sanberg, Paul R ^a  

^a Tampa General Medical Group   (United States)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Cerebrovascular disease; Fetal tissue; Ischemia; Neural transplantation; Stroke

Indexed keywords

ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CORPUS STRIATUM; DEGENERATIVE DISEASE; FETAL TISSUE TRANSPLANTATION; FETUS; GRAFT SURVIVAL; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; TISSUE REGENERATION;

EID: 0031056061     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/0149-7634(95)00063-1     Document Type: Article

References (85)

1. Aihara N., Mizukawa K., Koide K., Mabe H., Nishino H. Striatal grafts in infarct striatopallidum increase GABA release, reorganize GABA receptor and improve water-maze learning in rat. Brain Res. Bull. 33:1994;483-488.
2. American Heart Association. 1991 Heart and Stroke Facts. Dallas: American Heart Association National Center; 1991.
3. American Heart Association. Dallas: American Heart Association National Center; 1994.
4. Benderson J.B., Pitts L.H., Tsuji M. Rat middle cerebral artery occlusion: Evaluation of the model and development of neurologic examination. Stroke. 17:1986;472-476.
5. Bjorklund A., Stenevi U. Reconstruction of the nigrostriatal pathway by intracerebral nigral transplants. Brain Res. 177:1979;555-560.
6. Blomquvist, P.; Mabe, H.; Ingvar, M.; Siesjö, B. K. Models for studying long term recovery following forebrain ischemia in the rat. 1. Circulatory and functional effects of 4 vessel occlusion. Acta Neurol. Scand. 69: 376-84; 1984.
7. Borlongan C.V., Martinez R., Shytle R.D., Freeman T.B., Cahill D.W., Sanberg P.R. Striatal dopamine-mediated motor behavior is altered following occlusion of the middle cerebral artery. Pharmac. Biochem. Behav. 52:1995;225-229.
8. Borlongan C.V., Cahill D.W., Sanberg P.R. Locomotor and passive avoidance deficits following occlusion of the middle cerebral artery. Physiol. Behav. 58:1995;909-917.
9. Borlongan C.V., Koutouzis T.K., Randall T.S., Freeman T.B., Cahill D.W., Sanberg P.R. Systemic 3-nitropropionic acid: Behavioral deficits and striatal damage in adult Sprague-Dawley rats. Brain Res. Bull. 36:1995;549-556.
10. Bose B., Osterholm J.L., Berry R. A reproducible experimental model of focal cerebral ischemia in the cat. Brain Res. 311:1984;385-391.
11. Brierly, J.B.; Graham, D.I. Hypoxia and vascular disorders of the central nervous system. In: Hulme Adams, J.; Corsellis, J.A.N.; Duchen, L.W., eds. Greenfield's Neuropathology. London: Edward Arnold; 1984:125-207.
12. Buchan A.M., Yue D., Slivka A. A new model of temporary focal neocortical ischemia in the rat. Stroke. 23:1992;273-279.
13. Bullock R., Butcher S.P., Chen M.H., Kendall L., McCulloch J. Correlation of the extracellular glutamate concentration with extent of blood flow reduction after subdural hematoma in the rat. J. Neurosurg. 74:1991;794-802.
14. Chen M.H., Bullock R., Graham D.I., Miller J.D., McCulloch J. Ischemic neuronal damage after acute subdural hematoma in the rat: effects of pretreatment with a glutamate antagonist. J. Neurosurg. 74:1991;944-950.
15. Clarke D.J., Brundin P., Strecker R.E., Nilsson O.G., Bjorklund A., Lindvall O. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse using tyrosine hydroxylase immunocytochemistry. Exp. Brain Res. 73:1988;115-126.
16. Cummins J.L., Tomiyasu U., Read S., Benson D.F. Amnesia with hippocampal lesions after cardiopulmonary arrest. Neurology. 34:1984;679-681.
17. Deckel A.W., Moran T.H., Coyle J.T., Sanberg P.R., Robinson R.G. Anatomical predictors of behavioural recovery following fetal striatal transplants. Brain Res. 365:1986;249-258.
18. Dunnett S.B., Iversen S.D. Learning impairments following selective kainic acid induced lesions within the neostriatum of rats. Behav. Brain Res. 2:1981;189-209.
19. Emerich D.F., Ragozzino M., Lehaman M., Sanberg P.R. Behavioral effects of neural transplantation. Cell Transplant. 1:1992;401-427.
20. Emerich, D.F.; Sanberg, P.R. Animal models of Huntington's Disease. Animal models of neurological disease. In: Boulton, A.; Baker, G.; Butterworth, R., eds. Neuromethods, vol. 21. New Jersey: Humana Press; 1992:65-124.
21. Evarts, E. Brain control of movement: Possible mechanisms of functional reorganization. In: Bach-Y-Rita, P., ed. Recovery of Function: Theoretical Consideration for Brain Injury and Rehabilitation. Toronto: Huber; 1986:173-186.
22. Freeman T.B., Nauert G.M., Sanberg P.R., Kordower J.H. Influence of donor age on the survival of human embryonic dopaminergic neural grafts. J. Neural Transplant. Plast. 3:1993;257-258.
23. Freeman T.B., Olanow W.C., Hauser R.A., Naueryt G.M., Smith D.A., Borlongan C.F., Sanberg P.R., Holt D.A., Kordower J.H., Vingerjoets F.J.G., Snow B.J., Calne D., Gauger L.L. Bilateral fetal nigral transplantation into postcommisural putamen in Parkinson's disease. Ann. Neurol. 38:1995;379-388.
24. Freeman T.B., Sanberg P.R., Snow B.J., Vingerhoets F.J.G., Smith D.A., Borlongan C.V., Olanow C.W. Fetal nigral transplantation in Parkinson's disease: The USF experience. Soc. Neurosci. Abstr. 20:1994;9.
25. Frim D.M., Simpson J., Uhler T.A., Short M.P., Bossi S.R., Breakefield X.O., Isacson O. Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. J. Neurosci. Res. 35:1993;452-458.
26. Frim D.M., Uhler T.A., Short M.P., Ezzedine Z.D., Llagsbrun M., Breakefield X.O., Isacson O. Effects of biologically delivered NGF, BDNF, bFGF on striatal excitotoxic lesions. Neuroreport. 4:1993;367-370.
27. Glees, P. Functional reorganization following hemispherectomy in man and after small experimental lesion in primates. In: Bach-Y-Rita, P., ed. Recovery of Function: Theoretical Consideration for Brain Injury and Rehabilitation. Toronto: Huber; 1986:108-126.
28. Grabowski M., Brundin P., Johansson B.B. Functional integration of cortical grafts placed in brain infarcts of rats. Ann. Neurol. 34:1993;362-368.
29. Graham, D.I. Hypoxia and vacular disorders. In: Hulme Adams, J.; Duchen, L.W., eds. Greenfield's Neuropathology. London: Edward Arnold; 1992:153-268.
30. Graybiel A.M., Liu F.C., Dunnett S.B. Intrastriatal transplants of cells derived from fetal striatal primordia. I. Phenotype and modular organization. J. Neurosci. 9:1989;3250-3271.
31. Gustafson I., Westerberg E.J., Wieloch T. Extracellular brain cortical levels of noradrenaline in ischemia: Effects of desipramine and post-ischemic administration of idazoxan. Exp. Brain Res. 86:1991;555-561.
32. Henderson, B.T.H.; Clough, C.G.; Hitchcock, E.R.; Kenny, B.G. Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Lancet 1274; 1988.
33. Isacson O., Brundin P., Kelly P.A.T., Gage F.H., Bjorklund A. Functional neuronal placement by grafted striatal neurons in the ibotenic acid-lesioned striatum. Nature. 311:1984;458-460.
34. Isacson O., Brundin P., Gage F.H., Bjorklund A. Neural grafting in a rat model of Huntington's Disease: Progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting. Neuroscience. 16:1985;799-817.
35. Isacson O., Dunnett S.B., Bjorklund A. Graft induced behavioral recovery in an animal model of Huntington's Disease. Proc. Natn. Acad. Sci. USA. 83:1986;2728-2732.
36. Jones T.H., Morawetz R.B., Crowell R.M., Marcoux F.W., FitzGibbon S.J., DeGirolami U., Ojemann R.G. Thresholds of focal cerebral ischemia in awake monkeys. J. Neurosurg. 54:1981;773-782.
37. Joseph, R. Critical Issues in Neuropsychology. New York: Plenum Press; 1990:319-351.
38. Karpiak S.E., Tagliavia A., Wakade C.G. Animal models for the study of drugs in ischemic stroke. Ann. Rev. Pharmac. Toxic. 29:1989;403-414.
39. Koide K., Hashitani T., Aihara N., Mabe H., Nishino H. Improvement of passive avoidance task after grafting of fetal striatal cell suspensions in ischemic striatum in the rat. Rest. neurol. Neurosci. 5:1993;205-214.
40. Koizumi J., Yoshida Y., Nakazawa T., Ooneda G. Experimental studies of ischemic brain edema. 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic rats. Jpn. J. Stroke. 8:1986;1-8.
41. Kolb, B. Sparing and recovery of function. In: Kolb, B.; Tees, R.C., eds. The Cerebral Cortex of the Rat. Cambridge: MIT Press; 1990: 537-563.
42. Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J.G., Mufson E.J., Sanberg P.R., Hauser R.A., Smith D.A., Nauert M., Perl D.P., Olanow C.W. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1995;118-1124.
43. Levine S., Marvin K. Ischemic infarction and swelling in the rat brain. Arch. Pathol. 69:1960;76-85.
44. Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., Leenders K.L., Sawle G., Rothwell J.C., Marsden C.D., Bjorklund A. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science. 247:1990;574-577.
45. Lubic, L. G.; Palkowitz, H. P. Stroke, Second Edition. New York: Medical Examination Publishing Co., Inc.; 1983.
46. Markgraf C.G., Green E.J., Hurwitz B.E., Morikawa E., Dietrich W.D., McCabe P.M., Ginsburg M.D., Schneiderman N. Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats. Brain Res. 575:1992;238-246.
47. Markgraf C.G., Green E.J., Watson B., McCabe P.M., Schneiderman N., Dietrich W.D., Ginsburg M.D. Recovery of sensorimotor function after distal middle cerebral artery photothrombotic occlusion in rats. Stroke. 25:1994;153-159.
48. Mayer E., Brown V.J., Dunnet S.B., Robbins T.W. Striatal graft-associated recovery of a lesion-induced performance deficit in the rat requires learning to use the transplant. Eur. J. Neurosci. 4:1991;119-126.
49. McGeer, P.L.; Kimura, H.; McGeer, E.G. Neural Transplants. In: Sladek, J.R.; Gash, D.M., eds. Neural Transplants: Development and Function. New York: Plenum; 1984:361-371.
50. Meldrum B.S. Protection against ischemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc. Brain Metab. Rev. 2:1990;27-57.
51. Meldrum B.S. Excitatory amino acid receptors and disease. Curr. Opp. Neurol. Neurosurg. 5:1992;508-513.
52. Memezawa H., Minamisawa H., Smith M.-L., Siesjo B.K. Ischemic penumbra in a model of reversible cerebral artery occlusion in the rat. Exp. Brain Res. 89:1992;67-78.
53. Molinari G.F., Laurent J.P. A classification of experimental models of brain ischemia. Stroke. 7:1976;14-17.
54. Moncada C., Lekieffre D., Arvin B., Meldrum B.S. Effect of NO synthase inhibition on NMDA- and ischemia-induced hippocampal lesions. Neuroreport. 3:1992;530-532.
55. Nagasawa H., Kogure K. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke. 20:1989;1037-1043.
56. Nakahara I., Kikuchi H., Taki W., Nishi S., Kito M., Yonekawa Y., Goto Y., Ogata N. Changes in major phospholipids of mitochondria during postischemic reperfusion in rat brain. J. Neurosurg. 76:1992;244-250.
57. National Center for Health Statistics. health, United States, 1990. Hyattsville, MD: Public Health Service; 1991.
58. Nishino H., Czurkó A., Fukuda A., Hashitani T., Hida H., Karadi Z., Lénárd L. Pathophysiological process after transient ischemia of the middle cerebral artery in the rat. Brain Res. Bull. 35:1994;51-56.
59. Nishino, H.; Koide, K.; Aihara, N.; Kumazaki, M.; Sakurai, T.; Nagai, H. Striatal grafts in the ischemic striatum improve pallidal GABA release and passive avoidance. Brain Res. Bull. 32:517-20; 1993.
60. Olney, J.W. Neurotoxicity of excitatory amino acids. In: McGeer, E.; Olney, J. W.; McGeer, P., eds. Kainic acid as a tool in neurobiology. New York: Raven Press; 1978:201-217.
61. Pakzaban P., Deacon T.W., Burns L.H., Isacson O. Increased proportion of AChE-rich zones and improved morphological integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence. Exp. Brain Res. 97:1993;13-22.
62. Perlman S.H., Levivier M., Collier T.J., Sladek J.R., Gash D.M. Striatal implants protect the host striatum against quinolinic acid toxicity. Exp. Brain Res. 84:1991;303-310.
63. Perlow M.F., Freed W.F., Hoffer B., Seiger A., Olson L., Wyet R.J. Brain grafts reduce motor abnormalities produced by destruction of the nigrostriatal dopamine system. Science. 204:1979;643-647.
64. Petito C.K., Feldman E., Pulsinelli W.A., Plum F. Delayed neuronal hippocampal damage in human following cardiorespiratory arrest. Neurology. 37:1987;1281-1286.
65. Pritzel M., Isacson O., Brundin P., Wiklund L., Bjorklund A. Afferent and efferent connections of striatal transplants implanted into the ibotenic acid lesioned neostriatum in adult rats. Exp. Brain Res. 65:1986;112-126.
66. Pulsinelli, W.A.; Buchan, A. In: Ginsberg, M.D.; Dietrich, W.D., eds. Cerebrovascular Diseases. New York: Raven Press; 1989:87-91.
67. Pulsinelli W.A., Brierley J.B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11:1982;491-498.
68. Pundt L.L., Kondoh T., Conrad J.A., Low W.C. Human fetal striatum exhibits viable tissue and cells for transplantation from donors 7-18 weeks in gestation. Soc. Neurosci. Abstr. 20:1994;472.
69. Rod M.R., Auer R.N. Combination therapy with nimodipine and dizocilpine in a rat model of transient forebrain ischemia. Stroke. 23:1992;196-209.
70. Sanberg P.R. Haloperidol-induced catalepsy is mediated by post-synaptic dopamine receptors. Nature. 284:1980;472-473.
71. Sanberg P.R., Coyle J.T. Scientific approaches to Huntington's disease. CRC Critical Reviews in Clinical Neurobiology. 1:1984;1-44.
72. Sanberg, P.R.; Wiktorin, K.; Isacson, O. Cell Transplantation for Huntington's Disease. FL: R.G. Landes Co.; 1994a.
73. Sanberg P.R., Borlongan C.V., Freeman T.B., Koutouzis T.K., Cahill D.W., Isacson O., Pakzaban P. Transplantation of striatal human fetal tissue in excitotoxin model of Huntington's disease: Neuroanatomical and behavioral effects. Soc. Neurosci. Abstr. 20:1994;471.
74. Schmidt-Kastner R., Freund T.F. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience. 40:1991;599-636.
75. Siesjo B.K., Bengtsson F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia and speading depression: a unifying hypothesis. J. Cereb. Blood Flow Metab. 9:1989;127-140.
76. Siesjo B.K. Pathophysiology and treatment of focal cerebral ischemia: part I: Pathophysiology. J Neurosurg. 77:1992;169-184.
77. Tamura A., Nagashima H., Tsujita Y., Nakayama H., Kirino T., Sano K. Behavioral changes after cerebral infarction in rats. J. Cerebral Blood Flow Metab. 13:1993;53.
78. Toole, J. Cerebrovascular Disorders; with Chapters on applied embryology, vascular anatomy, and physiology of the brain and spinal cord. New York: McGraw Hill; 1974.
79. Tulipan N., Huang S., Whetsell U.O., Allen G.S. Neonatal striatal grafts prevent lethal syndrome produced by bilateral intrastriatal injection of kainic acid. Brain Res. 377:1986;163-167.
80. Tulipan N., Lou S.Q., Allen G.S., Whetsell U.O. Striatal grafts provide sustained protection from kainic and quinolinic acid-induced damage. Exp. Neurol. 102:1988;325-332.
81. Weinrauch V., Safar P., Fisherman S., Kuboyama K., Radovsky A. Beneficial effect of mild hypothermia and detrimental effect of deep hypothermia after cardiac arrest in dogs. Stroke. 23:1992;1454-1462.
82. Wictorin K., Clarke D.J., Bolam J.P., Bjorklund A. Host corticostriatal fibers establish synaptic connections with grafted striatal neurons in the ibotenic acid lesioned striatum. Eur. J. Neurosci. 1:1989;189-195.
83. Wictorin K., Simerly R.B., Isacson O., Swanson L.W., Bjorklund A. Connectivity of striatal transplants implanted into the ibotenic acid-lesioned striatum. II. Cortical afferents. Neuroscience. 30:1989;297-311.
84. Wolf P.A., Kannel W.B., McGee D.L., Meeks S.L., Bharucha N.E., McNamara P.M. Duration of atrial fibrillation and imminence of stroke: The Farmingham Study. Stroke. 14:1983;664-667.
85. Zorumski C.F., Olney J.W. Excitotoxic neuronal damage and neuropsychiatric disorders. Pharmac. Ther. 59:1993;145-162.